Smith & Nephew Plc (SNN)

42.34
0.31 0.74
NYSE : Health Technology
Prev Close 42.03
Open 42.36
Day Low/High 42.29 / 42.57
52 Wk Low/High 32.22 / 42.76
Volume 229.34K
Avg Volume 484.70K
Exchange NYSE
Shares Outstanding 437.42M
Market Cap 18.19B
EPS 1.50
P/E Ratio 55.30
Div & Yield 0.70 (1.66%)

Latest News

Smith & Nephew Launches New FLOW 90™ Wand At ISAKOS Joining Its Innovative Collection Of COBLATION™ Technology And Shoulder Repair Portfolios

Smith & Nephew Launches New FLOW 90™ Wand At ISAKOS Joining Its Innovative Collection Of COBLATION™ Technology And Shoulder Repair Portfolios

LONDON, May 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the U.

Sunniva Inc. Provides Strategic Update; Announces Fiscal 2018 Financial Results

Sunniva Inc. Provides Strategic Update; Announces Fiscal 2018 Financial Results

2018 gross revenue of $18.8 million, up from $16.

Sunniva Announces Acquistion Of Two Licenced Cannabis Companies To Expand Its Packaging And Distribution Capabilities In California

Sunniva Announces Acquistion Of Two Licenced Cannabis Companies To Expand Its Packaging And Distribution Capabilities In California

- Acquiring two California entities holding temporary distribution and manufacturing licences, respectively.

Sunniva Inc. Announces Collaborative Relationship Between Natural Health Services And UNIFOR To Provide Cannabis Education Services To UNIFOR Members

Sunniva Inc. Announces Collaborative Relationship Between Natural Health Services And UNIFOR To Provide Cannabis Education Services To UNIFOR Members

VANCOUVER, British Columbia, April 24, 2019 /PRNewswire/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") ( CSE: SNN) ( OTCQB: SNNVF), a North American provider of cannabis products and services, announced today that its wholly owned...

Sunniva Inc. To Announce 2018 Fourth Quarter And Year-End Results On April 29, 2019

Sunniva Inc. To Announce 2018 Fourth Quarter And Year-End Results On April 29, 2019

VANCOUVER, British Columbia, April 23, 2019 /PRNewswire/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") ( CSE: SNN) ( OTCQB: SNNVF), a North American provider of cannabis products and services plans to release its results for the fourth...

Sunniva Reports Filing Of Class Action Lawsuit Regarding Privacy Breach At Natural Health Services Ltd.

Sunniva Reports Filing Of Class Action Lawsuit Regarding Privacy Breach At Natural Health Services Ltd.

VANCOUVER, British Columbia, March 27, 2019 /PRNewswire/ -- Sunniva Inc. ("Sunniva", the "Company", "we", "our" or "us") ( CSE: SNN) ( OTCQB: SNNVF), reports that it has been named in a class action lawsuit, along with its wholly owned subsidiary, Natural...

Smith & Nephew POLAR3™ Total Hip Solution Demonstrates Best-in-class Results From World's Largest Registry

Smith & Nephew POLAR3™ Total Hip Solution Demonstrates Best-in-class Results From World's Largest Registry

LONDON, March 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today at the American Academy of Orthopaedic Surgeons annual meeting in Las Vegas presented data around its POLAR3 Total Hip Solution.

Smith & Nephew Acquires Brainlab Orthopaedic Joint Reconstruction Business

Smith & Nephew Acquires Brainlab Orthopaedic Joint Reconstruction Business

The two companies enter into a strategic collaboration for future development of technology for digital surgery across a broad range of clinical areas

Smith & Nephew Establishes Multi-asset Digital Surgery And Robotic Ecosystem

Smith & Nephew Establishes Multi-asset Digital Surgery And Robotic Ecosystem

LONDON, March 12, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces product launches and investments that establish its multi-asset digital surgery and robotic ecosystem.

Smith & Nephew Expands In High Growth Regenerative Medicine Market Through Acquisition Of Osiris Therapeutics, Inc.

Smith & Nephew Expands In High Growth Regenerative Medicine Market Through Acquisition Of Osiris Therapeutics, Inc.

LONDON, March 12, 2019 /PRNewswire/ -- Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces that it has agreed to acquire Osiris Therapeutics, Inc.

Here's How Medtronic Can Unlock Shareholder Value, Says Analyst

Here's How Medtronic Can Unlock Shareholder Value, Says Analyst

The appointment of Mike Weinstein as senior vice president of strategy has sparked the question of what the med tech firm should do to unlock shareholder value.

First Week Of SNN December 21st Options Trading

Investors in Smith & Nephew plc saw new options begin trading this week, for the December 21st expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Smith & Nephew: RCT Demonstrates A 71% Reduction In The Onset Of Sacral Pressure Ulcers When Adding ALLEVYN¿ LIFE To Standard Preventative Protocol

Smith & Nephew: RCT Demonstrates A 71% Reduction In The Onset Of Sacral Pressure Ulcers When Adding ALLEVYN¿ LIFE To Standard Preventative Protocol

Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the publication of a randomised controlled trial (RCT) demonstrating that the addition of ALLEVYN LIFE, Smith & Nephew's...

Activists Can Boost Shares: Cramer's 'Mad Money' Recap (Tuesday 10/10/17)

Activists Can Boost Shares: Cramer's 'Mad Money' Recap (Tuesday 10/10/17)

Activist investors have helped smaller shareholders win higher valuations for their holdings.

Smith & Nephew Surges to Record High on Reports of Elliott Stake

Smith & Nephew Surges to Record High on Reports of Elliott Stake

Paul Singer's Elliott is said to have started building a stake in the maker of artificial hips and knees, sending shares higher.

Cramer: Don't Fear the Activist

Cramer: Don't Fear the Activist

Their involvement can boost a company's stock.

Study Results Demonstrate 74% Reduction In Surgical Site Infections With Use Of PICO™ Single Use Negative Pressure Wound Therapy System

Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, proudly supports results of an independent, randomised clinical trial 1 concluding that, in the patients studied, the use of the PICO Single Use...

European Stocks Rise but London Blue Chips Slip on Stronger Pound

European Stocks Rise but London Blue Chips Slip on Stronger Pound

The FTSE 100 lagged its counterparts on Thursday following a run of broker downgrades and after a stronger pound ate into FX gains for London's blue chips.

Take Advantage of U.K. Budget to Bag Some Bargains

Take Advantage of U.K. Budget to Bag Some Bargains

Investors should look at cheap, inflation-proof stocks, which could be very cheap.

10 Safe Dividend Stocks for Protection Against Fed Rate Hikes

10 Safe Dividend Stocks for Protection Against Fed Rate Hikes

When interest rates rise, these quality dividend growth stocks should weather the storm.

Smith & Nephew Reinforces Strong Educational Commitment To Advanced Wound Management At World Union Of Wound Healing Societies Meeting (WUWHS)

Smith & Nephew Reinforces Strong Educational Commitment To Advanced Wound Management At World Union Of Wound Healing Societies Meeting (WUWHS)

Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, highlights three scientific symposia at World Union of Wound Health Societies (WUWHS) on 25-29 September 2016 in Florence, Italy.

Perrenial Target and Acquirer NuVasive Names New President and COO

Perrenial Target and Acquirer NuVasive Names New President and COO

The medical device company taps Jason Hannon, an 11-year company veteran, as its new president and COO, succeeding Patrick Miles, who was appointed vice chairman.

New Protocol Including The Use Of ALLEVYN™ LIFE Reduces Hospital-acquired Pressure Ulcers By 69% In Large Facility

New Protocol Including The Use Of ALLEVYN™ LIFE Reduces Hospital-acquired Pressure Ulcers By 69% In Large Facility

Smith & Nephew (LSE:SN)(NYSE:SNN), the global medical technology business, announces the publication of a new research paper showing how a comprehensive ulcer prevention programme which included the use of...

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

Rival Offer for LDR Is Unlikely, but Never Say Never

Rival Offer for LDR Is Unlikely, but Never Say Never

The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.

Medtronic Strikes Deals in Gynecology, Robotics

Medtronic Strikes Deals in Gynecology, Robotics

The medical device company is spending $350 million for the gynecology business of Smith & Nephew, and has agreed to invest in an Israeli spinal robotics company.

Government Probes for Valeant; New Board Members Put Forth

Government Probes for Valeant; New Board Members Put Forth

The embattled pharmaceutical company's move to bring in additional directors and file an overdue financial report did little to appease the markets.

Stryker Strikes Again, Buying Physio-Control

Stryker Strikes Again, Buying Physio-Control

Medical device company Stryker is paying $1.2 billion cash for defibrillator maker Physio-Control on the heels of spending $2.8 billion on disposable health care devices manufacturer Sage Products.